Cite
APA Citation
Ryan, C., Brander, D., Barr, P., Tyekucheva, S., Ren, Y., Hackett, L., McDonough, M., Pena Del Aguila, K., McEwan, M., Collins, M., Abramson, J., Jacobsen, E., LaCasce, A., Fisher, D., Brown, J., & Davids, M. (n.d.). p674: UPDATED RESULTS OF A PHASE 1B STUDY OF IBRUTINIB (IBR) PLUS OBINUTUZUMAB (OBIN) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). HemaSphere, 6, 572–573. http://access.bl.uk/ark:/81055/vdc_100159756159.0x000009